MT2016-10 :A Phase 2a, Dose-Escalation, Open-Label Study

  • Arora, Mukta (PI)
  • Lazaryan, Aleksandr (Prior Principal Investigator)

Project: Research project

Project Details

Description

MT2016-10 :A Phase 2a, Dose-Escalation, Open-Label Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects with Chronic Graft Versus Host Disease
StatusActive
Effective start/end date4/20/166/30/20

Funding

  • KADMON CORPORATION, LLC

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.